272
Views
6
CrossRef citations to date
0
Altmetric
Research Articles

Molecular dynamics and 3D-QSAR studies on indazole derivatives as HIF-1α inhibitors

ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon
Pages 3524-3541 | Received 09 Dec 2021, Accepted 05 Mar 2022, Published online: 23 Mar 2022
 

Abstract

Hypoxia-inducible factor (HIF) is a transcriptional factor which plays a crucial role in tumour metastasis thereby responsible for development of various forms of cancers. Indazole derivatives have been reported in the literature as potent HIF-1α inhibitor via interaction with key residues of the HIF-1α active site. Taking into consideration the role HIF-1α in cancer and potency of indazole derivative against HIF-1α; it was considered of interest to correlate structural features of known indazole derivatives with specified HIF-1α inhibitory activity to map pharmacophoric features through Three-dimensional quantitative structural activity relationship (3D-QSAR) and pharmacophore mapping. Field and Gaussian based 3D-QSAR studies were performed to realize the variables influencing the inhibitory potency of HIF-1α inhibitors. Field and Gaussian- based 3D-QSAR models were validated through various statistical measures generated by partial least square (PLS). The steric and electrostatic maps generated for both 3D-QSAR provide a structural framework for designing new inhibitors. Further; 3D-maps were also helpful in understanding variability in the activity of the compounds. Pharmacophore mapping also generates a common five-point pharmacophore hypothesis (A1D2R3R4R5_4) which can be employed in combination with 3D-contour maps to design potent HIF-1α inhibitors. Molecular docking and molecular dynamics (MD) simulation of the most potent compound 39 showed good binding efficiency and was found to be quite stable in the active site of the HIF-1α protein. The developed 3D-QSAR models; pharmacophore modelling; molecular docking studies along with the MD simulation analysis may be employed to design lead molecule as selective HIF-1α inhibitors for the treatment of Cancer.

Acknowledgements

Yogesh is grateful to All India Council for Technical Education (AICTE) for providing GPAT fellowship. Author`s acknowledges Department of Science and Technology (DST) for providing the Departmental DST-FIST grant (SR/FST/LSI-656/2016) to the Department of Pharmaceutical Sciences and Natural Products, Central University of Punjab, India.

Ethics approval

Not applicable.

Disclosure statement

The authors declare that they have no conflict of interest. S.T conceptualized the present research. The computational methodology and formal analysis were performed by Y.S., K.S.S. and P.K. MD simulation and analysis were performed by S.S. and Y.S. The interpretation of all the results and original draft of manuscript was prepared by S.T., P.K., Y.S. and K.S.S.

Consent to participate

Not applicable.

Consent for publication

Not applicable.

Code availability

Not applicable.

Funding

The author(s) reported there is no funding associated with the work featured in this article.

Data availability statement

Not applicable.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.